Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Journal Information
Journal Title: Arthritis Res Ther
Detailed journal information not available.
Publication Details
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study was performed per the Declaration of Helsinki and was approved by the Investigation and Ethics Committee at Nagasaki University Hospital (approval nos. 18061802 and 20021020). Informed consent was obtained from all participants before study enrollment, and patient information was anonymized and de-identified before analysis. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding No specific funding was received from public, commercial, or nonprofit bodies to conduct the work described in this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025